Medical Tubing Market

Medical Tubing Market Segmentation by Material (PVC, Polyolefin, TPE & TPU, and Silicone); by Application (Bulk Disposable Tubing, Catheters, and Drug Delivery Systems); and by End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Medical Labs, and Others) – Global Demand Analysis & Opportunity Outlook 2030

Buy Now
Report ID: 3536 | Published On: Apr 07, 2022
  1. Introduction
    • Market Definition
    • Market Segmentation
    • Product Overview
  2. Assumptions and Acronyms
  3. Research Methodology
  4. Research Process
    • Primary Research
    • Manufacturers
    • Distributors
    • End Users
    • Secondary Research
    • Market Size Estimation
  5. Executive Summary - Global Advanced Therapy Medicinal Products Market
  6. Analysis of Market Dynamics
  7. Drivers
  8. Trends
  9. Key Market Opportunities for Business Growth
  10. Major Roadblocks for the Market Growth
  11. Regulatory & Standard Landscape
  12. Value Chain Analysis
  13. Potential ATMP Treatment Analysis
  14. Pricing Analysis of Global Advanced Therapy Medicinal Products Market
  15. Use Case Analysis
  16. Pipeline Analysis
  17. Analysis on the Manufacturing Process
  18. Analysis of COVID-19 Impact on the Global Advanced Therapy Medicinal Products Market
  19. Analysis of End-User Market Share of Global Advanced Therapy Medicinal Products
  20. Competitive Positioning
  21. Competitive Landscape
  22. Market Share Analysis of Major Players (%), 2021
  23. Competitive Benchmarking
  24. Novartis AG.
  25. Takeda Pharmaceutical Company Limited
  26. Gilead Sciences, Inc.
  27. Bluebird Bio, Inc
  28. BioMarin Pharmaceutical Inc
  29. Vericel Corporation
  30. Mallinckrodt Pharmaceuticals
  31. UniQure N.V.
  32. JCR Pharmaceuticals Co., Ltd.
  33. Spark Therapeutics, Inc. (Parent Company: Roche)
  34. Kolon TissueGene, Inc.
  35. Global Advanced Therapy Medicinal Products Market Outlook
  36. By Value (USD million)
  37. By Product
  38. CAR-T Therapy, 2021-2031F (USD million)
  39. Gene Therapy, 2021-2031F (USD million)
  40. Cell Therapy, 2021-2031F (USD million)
  41. Tissue Engineered Product, 2021-2031F (USD million)
  42. By Disease
  43. Oncology, 2021-2031F (USD million)
  44. Genetic Disorders, 2021-2031F (USD million)
  45. CNS, 2021-2031F (USD million)
  46. Dermatology, 2021-2031F (USD million)
  47. Others, 2021-2031F (USD million)
  48. By End-User
  49. Hospitals & Clinics, 2021-2031F (USD million)
  50. Research & Academic Institutes, 2021-2031F (USD million)
  51. Global Advanced Therapy Medicinal Products Market by Region
  52. North America, 2021-2031F (USD million)
  53. Europe, 2021-2031F (USD million)
  54. Asia-Pacific, 2021-2031F (USD million)
  55. Latin America, 2021-2031F (USD million)
  56. Middle East & Africa, 2021-2031F (USD million)
  57. North America Advanced Therapy Medicinal Products Market Outlook
  58. By Value (USD million)
  59. By Product
  60. CAR-T Therapy, 2021-2031F (USD million
  61. Gene Therapy, 2021-2031F (USD million)
  62. Cell Therapy, 2021-2031F (USD million)
  63. Tissue Engineered Product, 2021-2031F (USD million)
  64. By Disease
  65. Oncology, 2021-2031F (USD million)
  66. Genetic Disorders, 2021-2031F (USD million)
  67. CNS, 2021-2031F (USD million)
  68. Dermatology, 2021-2031F (USD million)
  69. Others, 2021-2031F (USD million)
  70. By End-User
  71. Hospitals & Clinics, 2021-2031F (USD million)
  72. Research & Academic Institutes, 2021-2031F (USD million)
  73. By Country
  74. US, 2021-2031F (USD million)
  75. Canada, 2021-2031F (USD million)
  76. Europe Advanced Therapy Medicinal Products Market Outlook
  77. By Product
  78. By Disease
  79. By End User
  80. By Country
  81. UK, 2021-2031F (USD Million)
  82. Germany, 2021-2031F (USD Million)
  83. France, 2021-2031F (USD Million)
  84. Italy, 2021-2031F (USD Million)
  85. Spain, 2021-2031F (USD Million)
  86. Russia, 2021-2031F (USD Million)
  87. Netherlands, 2021-2031F (USD Million)
  88. Rest of Europe, 2021-2031F (USD Million)
  89. Asia Pacific Advanced Therapy Medicinal Products Market Outlook
  90. By Product
  91. By Disease
  92. By End User
  93. By Country
  94. China, 2021-2031F (USD Million)
  95. India, 2021-2031F (USD Million)
  96. Japan, 2021-2031F (USD Million)
  97. South Korea, 2021-2031F (USD Million)
  98. Singapore, 2021-2031F (USD Million)
  99. Australia, 2021-2031F (USD Million)
  100. Rest of Asia-Pacific, 2021-2031F (USD Million)
  101. Latin America Advanced Therapy Medicinal Products Market Outlook
  102. By Product
  103. By Disease
  104. By End User
  105. By Country
  106. Brazil, 2021-2031F (USD Million)
  107. Argentina, 2021-2031F (USD Million)
  108. Mexico, 2021-2031F (USD Million)
  109. Rest of Latin America, 2021-2031F (USD Million)
  110. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook
  111. By Product
  112. By Disease
  113. By End User
  114. By Country
  115. GCC, 2021-2031F (USD Million)
  116. Israel, 2021-2031F (USD Million)
  117. South Africa, 2021-2031F (USD Million)
  118. Rest of Middle East & Africa, 2021-2031F (USD Million)

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.


In The News

  • September 11, 2020- NewAge Industries announced its plan to recycle the waste generated from its silicone tubing and braid reinforced hose extrusion processes.

  • June 1, 2020- Nordson Corporation acquired Flurotek, Inc., to expand its medical tubing and other differentiated products offerings for complex medical devices.


Global Medical Tubing Market Highlights 2022 – 2030

The global medical tubing market is estimated to garner a sizeable revenue and grow at a CAGR of ~9% over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to growing demand for catheters and cannulas in hospitals around the world, and increasing availability of cost-competitive medical-grade plastics. Along with these, rising consumer access to healthcare supplies worldwide, and escalating demand for medical devices that incorporate tubing are also expected to drive market growth in the forthcoming years. Furthermore, rise in individual incomes, coupled with high occurrence of chronic disorders, and rapidly increasing geriatric population are projected to offer ample growth opportunities to the market in the near future. According to the World Health Organization, the total population of people aged 80 years or above was 125 million in 2018. By 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015.

Medical Tubing Market

Get more information on this reportDownload Sample PDF

The market is segmented by material into PVC, polyolefin, TPE & TPU, and silicone, out of which, the PVC segment is anticipated to hold the largest share in the global medical tubing market. This can be accounted to the ability of PVC to meet the diverse requirements of the healthcare industry, and largescale usage of the product in medical tube manufacturing. Apart from these, the silicone tubing segment is also assessed to gather a significant share, which can be credited to the flexibility, high tensile strength, and superior chemical resistance of silicone. Additionally, on the basis of application, the drug delivery systems segment is projected to witness the highest CAGR during the forecast period owing to the increasing purchasing power and disposable income worldwide, and rising investments by governments to provide improved healthcare. 


Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.


Global Medical Tubing Market Regional Synopsis

On the basis of geographical analysis, the global medical tubing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in the Asia Pacific is estimated to witness noteworthy growth over the forecast period on the back of the growing demand for medical tubing in China and India, and rise in government initiatives for providing premium-quality healthcare facilities. In addition, high geriatric population is also expected to boost the region’s market growth in the future. Moreover, the market in North America is projected to occupy the largest share during the forecast period ascribing to the large healthcare spending, and strong presence of well-established medical facilities and major market players. As per the Centers for Medicare and Medicaid Services, U.S. health care spending grew 4.6 percent in 2019, reaching USD 3.8 trillion.  As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent.

The global medical tubing market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis


Medical Tubing Market
Get more information on this report: Request Sample PDF

Market Segmentation

Our in-depth analysis of the global medical tubing market includes the following segments:

By Material

  • PVC
  • Polyolefin
  • TPE & TPU
  • Silicone

By Application

  • Bulk Disposable Tubing
  • Catheters
  • Drug Delivery Systems

By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Medical Labs
  • Others


Growth Drivers
  • Growing Demand for Catheters and Cannulas in Hospitals Worldwide
  • Increasing Availability of Cost-Competitive Medical-Grade Plastics

Challenges

  • Significant Investments Required for Product Development


Healthcare Expenditure
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    • Nordson Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • NewAge Industries, Inc.
    • TE Connectivity Ltd.
    • Freudenberg and Co. KG.
    • RAUMEDIC AG
    • Lubrizol Corporation
    • W. L. Gore & Associates, Inc.
    • Vention Medical, Inc.
    • Teknor Apex Company
    • Freudenberg Medical, LLC

Key Questions Answered in the Report

1) What are the major factors driving the growth of the medical tubing market?

Ans: The major factors driving market growth are growing demand for catheters and cannulas in hospitals worldwide and increasing availability of cost-competitive medical-grade plastics.

2) What would be the CAGR of medical tubing market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2022 – 2030.

3) What are the challenges affecting the medical tubing market growth?

Ans: Significant investments required for product development is estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of medical tubing market in future?

Ans: Asia Pacific will provide more business opportunities for market growth owing to the growing demand for medical tubing, and rising government initiatives for providing premium-quality healthcare facilities.

5) Who are the major players dominating the medical tubing market?

Ans: The major players in the market are Nordson Corporation, NewAge Industries, Inc., TE Connectivity Ltd., Freudenberg and Co. KG., RAUMEDIC AG, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the medical tubing market?

Ans: The market is segmented by material, application, end user, and by region.

8) Which segment captures the largest market size in the material segment in the medical tubing market?

Ans: The PVC segment is anticipated to hold largest market size and is estimated to grow at a notable CAGR over the forecast period and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample